dicyandiamido has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carroll, WA; Donnelly-Roberts, DL; Faltynek, CR; Honore, P; Hsieh, GC; Jarvis, MF; Namovic, MT; Peddi, S; Perez-Medrano, A; Shuai, Q; Wang, Y | 1 |
| Colli, E; Digesu, GA; Olivieri, L | 1 |
1 review(s) available for dicyandiamido and Disease Models, Animal
| Article | Year |
|---|---|
Overactive bladder treatments in early phase clinical trials.
Topics: Animals; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Disease Models, Animal; Drugs, Investigational; Guanidines; Humans; Mice; Muscarinic Antagonists; Quinuclidines; Receptors, Muscarinic; Sensitivity and Specificity; Severity of Illness Index; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2007 |
1 other study(ies) available for dicyandiamido and Disease Models, Animal
| Article | Year |
|---|---|
Discovery and biological evaluation of novel cyanoguanidine P2X(7) antagonists with analgesic activity in a rat model of neuropathic pain.
Topics: Analgesics; Animals; Disease Models, Animal; Drug Administration Routes; Drug Design; Drug Discovery; Guanidines; Inhibitory Concentration 50; Neuralgia; Pain; Purinergic P2 Receptor Antagonists; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Structure-Activity Relationship; Treatment Outcome | 2009 |